Increased TSPO expression, pyroglutamate-modified amyloid beta (AβN3(pE)) accumulation and transient clustering of microglia in the thalamus of Tg-SwDI mice

J Neuroimmunol. 2023 Sep 15:382:578150. doi: 10.1016/j.jneuroim.2023.578150. Epub 2023 Jul 13.

Abstract

Epidemiological studies showed that Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA) frequently co-occur; however, the precise mechanism is not well understood. A unique animal model (Tg-SwDI mice) was developed to investigate the early-onset and robust accumulation of both parenchymal and vascular Aβ in the brain. Tg-SwDI mice have been extensively used to study the mechanisms of cerebrovascular dysfunction, neuroinflammation, neurodegeneration, and cognitive decline observed in AD/CAA patients and to design biomarkers and therapeutic strategies. In the present study, we documented interesting new features in the thalamus of Tg-SwDI mice: 1) a sharp increase in the expression of ionized calcium-binding adapter molecule 1 (Iba-1) in microglia in 6-month-old animals; 2) microglia clustering at six months that disappeared in old animals; 3) N-truncated/modified AβN3(pE) peptide in 9-month-old female and 12-month-old male mice; 4) an age-dependent increase in translocator protein (TSPO) expression. These findings reinforce the versatility of this model for studying multiple pathological issues involved in AD and CAA.

Keywords: Alzheimer's disease; Cerebral amyloid angiopathy; Neuroinflammation; Tg-SwDI mouse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / complications
  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides
  • Animals
  • Brain / metabolism
  • Cerebral Amyloid Angiopathy* / complications
  • Cerebral Amyloid Angiopathy* / genetics
  • Cerebral Amyloid Angiopathy* / metabolism
  • Disease Models, Animal
  • Female
  • Male
  • Mice
  • Mice, Transgenic
  • Microglia / metabolism
  • Pyrrolidonecarboxylic Acid / metabolism
  • Pyrrolidonecarboxylic Acid / therapeutic use
  • Thalamus / metabolism

Substances

  • Amyloid beta-Peptides
  • Pyrrolidonecarboxylic Acid
  • Bzrp protein, mouse
  • Aif1 protein, mouse